Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: A pilot study

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 9, 2009, Pages 1062-1067

  Gimeno García, Antonio Z ^a   Quintero, Enrique ^a   Nicolás Pérez, David ^a   Hernández Guerra, Manuel ^a   Parra Blanco, Adolfo ^a   Jiménez Sosa, Alejandro ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Colorectal cancer screening; First degree relatives; Immunochemical fecal occult blood test

Indexed keywords

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER DIAGNOSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DYSPLASIA; FAMILIAL CANCER; FAMILIAL DISEASE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FAMILY HEALTH; FEMALE; GUAIAC; HUMANS; INDICATORS AND REAGENTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PILOT PROJECTS; RISK FACTORS; SPAIN;

EID: 69549117277     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283293797     Document Type: Article

References (28)

1. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: guidelines and rationale. Gastroenterology 1997; 112:594-642. (Pubitemid 27078848)
2. Burt RW. Colon cancer screening. Gastroenterology 2000; 119:837-853.
3. Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA, et al. Screening behavior of individuals at high-risk for colorectal cancer. Gastroenterology 2005; 128:280-287. (Pubitemid 40431081)
4. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96:2992-3003. (Pubitemid 32959544)
5. Eisen GM, Weinberg DS. Narrative review: screening for colorectal cancer in patients with a first-degree relative with colonic neoplasia. Ann Intern Med 2005; 143:190-198.
6. Pickhardt PJ, Nugent PA, Mysliwiec PA, Choi JR, Schindler WR. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004; 141:352-359.
7. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112:17-23. (Pubitemid 27008980)
8. Codori AM, Petersen GM, Miglioretti DL. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 2001; 33:128-136. (Pubitemid 32744641)
9. Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, et al. Low compliance with colonoscopic screening in first degree relatives of patients with large adenomas. Aliment Pharmacol Ther 2006; 24:101-109. (Pubitemid 43894010)
10. Kristinsson J, Nygaard K, Aadland E, Barstad S, Sauar J, Hofstad B, et al. Screening of first-degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. Hemoccult II. Digestion 2001; 64:104-110. (Pubitemid 34701878)
11. Houlston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ 1990; 301:18-25.
12. Stephenson BM, Murday VA, Finan PJ, Stephenson BM, Murday VA, Finan PJ, et al. Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut 1993; 34:96-100.
13. Cripps NPJ, Heald RJ. Family based colorectal cancer screening in a district hospital. Gut 1996; 38:421-425. (Pubitemid 26074322)
14. Hunt LM, Rooney PS, Bostock K, Robinson MH, Hardcastle JD, Armitage NC, et al. Chemical and immunological testing for fecal occult blood in screening subjects at risk of familial colorectal cancer. Gut 1997; 40:110-112. (Pubitemid 27079761)
15. Robinson MHE, Kronborg O, Williams CB, Bostock K, Rooney PS, Hunt LM, et al. Fecal occult blood testing and colonoscopy in the surveillance of subjects at high-risk of colorectal neoplasia. Br J Surg 1995; 82:318-320.
16. Quintero E, Gimeno-Garcia AZ, Parra-Blanco A, Nicolas D, Moreno SG, Jiménez A, et al. One-time screening with an immunochromatographic occult blood test predicts the detection of advanced adenoma and colorectal cancer in the average-risk population. Can J Gastroenterol 2005; 19 (Suppl B):21B.
17. Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y. A quantitative immunochemical fecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Aliment Pharmacol Ther 2006; 23:1359-1364.
18. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of a guaiac-based and inmunochemical fecal occult blood test in screening for colorectal cancer in general average-risk population. Gut 2007; 56:210-214. (Pubitemid 46246209)
19. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. Can quantification of fecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer? Aliment Pharmacol Ther 2006; 24:1475-1481.
20. Rozen P, Levin B, Young GP. Who is at risk from familial colorectal cancer and how can they be managed? In: Rozen P, Young GP, Levin B, Spann SJ, editors. Colorectal cancer in clinical practice. 2nd ed. London: Taylor and Francis; 2005. pp. 67-84.
21. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on the new evidence. Gatroenterology 2003; 124:544-560. (Pubitemid 36169269)
22. Pariente A, Milan C, Lafon J. Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer: a case-control study. Gastroenterology 1998; 115:7-12. (Pubitemid 28307281)
23. Colombo L, Corti G, Magri F, Marocchi A, Brambilla P, Crespi C, et al. Results of a pilot study of endoscopic screening of first-degree relatives of colorectal cancer patients in Italy. J Epidemiol Community Health 1997; 51:453-458. (Pubitemid 27399539)
24. Ransohoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity. JAMA 1990; 264:76-78.
25. Kaiser P. Immunochemical versus guaiac-fecal occult blood tests. Tec Assessment Program 2004; 19:1-28.
26. Subramanian S, Klosterman M, Amonkar MM. Adherence with colorectal cancer screening guidelines: a review. Prev Med 2004; 38:536-550. (Pubitemid 38452879)
27. Bampton PA, Sandford JJ, Cole SR, Smith A, Morcom J, Cadd B, et al. Interval fecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut 2005; 54:803-806. (Pubitemid 40732097)
28. Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004; 292:1480-1489. (Pubitemid 39258342)